[Combined fibrinolytic-clearing treatment in obliterative endareteritis in the aged patient].
D000255:Adenosine Triphosphate / Q000627:therapeutic use*; D000367:Age Factors; D000368:Aged; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy*; D001205:Ascorbic Acid / Q000627:therapeutic use*; D005260:Female; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy; D007866:Leg / Q000098:blood supply*; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use*
D009539:Nicotinic Acids; D000255:Adenosine Triphosphate; D006493:Heparin; D001205:Ascorbic Acid
Trattamento fibrilinolitico chiarificante di associazione nell'endoarterite obliterante dell'anziano.